Challenges During the Reproductive Years: State of the Art
DOI:
https://doi.org/10.24950/rspmi.2773Keywords:
Autoimmune Diseases, FertilityDownloads
References
1. Singh M, Wambua S, Lee SI, Okoth K, Wang Z, Fayaz FF, et al. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. BMC Med.2024;22:94. doi:10.1186/s12916-024-03309-y
2. Andreoli L, García-Fernández A, Chiara Gerardi M, Tincani A. The Course of Rheumatic Diseases During Pregnancy. Isr Med Assoc J. 2019;21:464-70.
3. Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795-810. doi:10.1136/annrheumdis-2015-208840
4. Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology. 2023;62:e48-e88. doi:10.1093/rheumatology/keac551
5. Zhu J, Zhu Q, Li X, Shen T, Shi X, Zhao T. Systemic lupus erythematosus and male reproductive health: A systematic review and meta-analysis. Autoimmun Rev. 2025;24:103742. doi:10.1016/j.autrev.2025.103742
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Internal Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna



